Works about POLYCYSTIC kidney disease
Results: 2880
An unusual presentation of autosomal dominant polycystic kidney disease in a newborn.
- Published in:
- Pan African Medical Journal, 2024, v. 48, p. 1, doi. 10.11604/pamj.2024.48.146.44523
- By:
- Publication type:
- Article
Advances and Challenges in Modeling Autosomal Dominant Polycystic Kidney Disease: A Focus on Kidney Organoids.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 523, doi. 10.3390/biomedicines13020523
- By:
- Publication type:
- Article
Segmentation of ADPKD Computed Tomography Images with Deep Learning Approach for Predicting Total Kidney Volume.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 263, doi. 10.3390/biomedicines13020263
- By:
- Publication type:
- Article
Maligne Hyperthermie.
- Published in:
- Wiener Klinische Wochenschrift, 2003, v. 115, n. 15/16, p. 556, doi. 10.1007/BF03040449
- By:
- Publication type:
- Article
Risk assessment of incidentally detected complex renal cysts in children: potential role for a modification of the Bosniak classification.
- Published in:
- Current Medical Literature: Urology, 2008, v. 14, n. 3, p. 82
- Publication type:
- Article
Molecular evolution of PKD2 gene family in mammals.
- Published in:
- Genetica, 2009, v. 137, n. 1, p. 77
- By:
- Publication type:
- Article
Pkd1 and Wnt5a genetically interact to control lymphatic vascular morphogenesis in mice.
- Published in:
- Developmental Dynamics, 2022, v. 251, n. 2, p. 336, doi. 10.1002/dvdy.390
- By:
- Publication type:
- Article
The novel gene apnoia regulates Drosophila tracheal tube size.
- Published in:
- Developmental Dynamics, 2019, v. 248, n. 6, p. 477, doi. 10.1002/dvdy.29
- By:
- Publication type:
- Article
Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 7, p. 659, doi. 10.1007/s10157-022-02200-5
- By:
- Publication type:
- Article
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 6, p. 540, doi. 10.1007/s10157-022-02192-2
- By:
- Publication type:
- Article
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 12, p. 1292, doi. 10.1007/s10157-021-02097-6
- By:
- Publication type:
- Article
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 11, p. 1163, doi. 10.1007/s10157-021-02111-x
- By:
- Publication type:
- Article
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 11, p. 1231, doi. 10.1007/s10157-021-02100-0
- By:
- Publication type:
- Article
Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 9, p. 1003, doi. 10.1007/s10157-021-02083-y
- By:
- Publication type:
- Article
A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 9, p. 944, doi. 10.1007/s10157-021-02080-1
- By:
- Publication type:
- Article
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 9, p. 970, doi. 10.1007/s10157-021-02068-x
- By:
- Publication type:
- Article
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 8, p. 902, doi. 10.1007/s10157-021-02059-y
- By:
- Publication type:
- Article
iPSC technology-based regenerative medicine for kidney diseases.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 6, p. 574, doi. 10.1007/s10157-021-02030-x
- By:
- Publication type:
- Article
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 5, p. 467, doi. 10.1007/s10157-020-02009-0
- By:
- Publication type:
- Article
Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 3, p. 251, doi. 10.1007/s10157-020-01988-4
- By:
- Publication type:
- Article
Renal stones in patients with autosomal dominant polycystic kidney disease, a treatment challenge?
- Published in:
- 2020
- By:
- Publication type:
- Letter
Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 9, p. 748, doi. 10.1007/s10157-020-01928-2
- By:
- Publication type:
- Article
Laparoscopic ureterolithotomy, flexible ureteroscopic lithotripsy and percutaneous nephrolithotomy for treatment of upper urinary calculi in patients with autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 9, p. 842, doi. 10.1007/s10157-020-01882-z
- By:
- Publication type:
- Article
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 6, p. 500, doi. 10.1007/s10157-020-01856-1
- By:
- Publication type:
- Article
The relationship between liver cyst volume and QOL in Japanese ADPKD patients.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 4, p. 314, doi. 10.1007/s10157-019-01830-6
- By:
- Publication type:
- Article
ADPKD and metformin: from bench to bedside.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 10, p. 1188, doi. 10.1007/s10157-019-01752-3
- By:
- Publication type:
- Article
Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 9, p. 1130, doi. 10.1007/s10157-019-01748-z
- By:
- Publication type:
- Article
Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 8, p. 1022, doi. 10.1007/s10157-019-01736-3
- By:
- Publication type:
- Article
Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 4, p. 455, doi. 10.1007/s10157-018-1669-9
- By:
- Publication type:
- Article
Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 1, p. 100, doi. 10.1007/s10157-018-1617-8
- By:
- Publication type:
- Article
Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 5, p. 1213, doi. 10.1007/s10157-018-1574-2
- By:
- Publication type:
- Article
Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD).
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 5, p. 1079, doi. 10.1007/s10157-018-1545-7
- By:
- Publication type:
- Article
Diagnostic utility of <sup>18</sup>FDG-PET/CT for ADPKD cyst infection.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 4, p. 973, doi. 10.1007/s10157-017-1482-x
- By:
- Publication type:
- Article
Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 3, p. 583, doi. 10.1007/s10157-017-1486-6
- By:
- Publication type:
- Article
Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 3, p. 550, doi. 10.1007/s10157-017-1475-9
- By:
- Publication type:
- Article
A potentially crucial role of the <italic>PKD1</italic> C-terminal tail in renal prognosis.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 2, p. 395, doi. 10.1007/s10157-017-1477-7
- By:
- Publication type:
- Article
Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 3, p. 375, doi. 10.1007/s10157-016-1297-1
- By:
- Publication type:
- Article
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 2, p. 203, doi. 10.1007/s10157-016-1289-1
- By:
- Publication type:
- Article
Evidence-based clinical practice guidelines for polycystic kidney disease 2014.
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 4, p. 493, doi. 10.1007/s10157-015-1219-7
- By:
- Publication type:
- Article
Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 1, p. 147, doi. 10.1007/s10157-015-1134-y
- By:
- Publication type:
- Article
In Reply to 'The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease'.
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 1, p. 149, doi. 10.1007/s10157-015-1154-7
- By:
- Publication type:
- Article
Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 6, p. 1199, doi. 10.1007/s10157-015-1101-7
- By:
- Publication type:
- Article
Atrial septum aneurysm: an unusual manifestation in ADPKD?
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 6, p. 1206, doi. 10.1007/s10157-015-1113-3
- By:
- Publication type:
- Article
Exploring urinary biomarkers in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 5, p. 968, doi. 10.1007/s10157-014-1078-7
- By:
- Publication type:
- Article
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 5, p. 867, doi. 10.1007/s10157-015-1086-2
- By:
- Publication type:
- Article
Effect of everolimus on polycystic liver volume in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 4, p. 757, doi. 10.1007/s10157-014-1059-x
- By:
- Publication type:
- Article
Umbilical hernia in autosomal dominant polycystic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 1, p. 154, doi. 10.1007/s10157-013-0927-0
- By:
- Publication type:
- Article
Arterial aneurysms: autosomal dominant polycystic kidney disease, Marfan syndrome or both?
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 4, p. 672, doi. 10.1007/s10157-013-0876-7
- By:
- Publication type:
- Article